1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Anti-allergy
  • 1.2.3 Anti-VEGF Agents
  • 1.2.4 Anti-inflammatory
  • 1.2.5 Anti-glaucoma
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Ophthalmic Therapeutics/Drug Market Share by Application: 2020 VS 2026
  • 1.3.2 Dry Eye
  • 1.3.3 Allergies
  • 1.3.4 Glaucoma
  • 1.3.5 Infection
  • 1.3.6 Retinal Disorders
  • 1.3.7 Uveitis
  • 1.3.8 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Ophthalmic Therapeutics/Drug Market Perspective (2015-2026)
• 2.2 Global Ophthalmic Therapeutics/Drug Growth Trends by Regions
  • 2.2.1 Ophthalmic Therapeutics/Drug Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Ophthalmic Therapeutics/Drug Historic Market Share by Regions (2015-2020)
  • 2.2.3 Ophthalmic Therapeutics/Drug Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Ophthalmic Therapeutics/Drug Players by Market Size
  • 3.1.1 Global Top Ophthalmic Therapeutics/Drug Players by Revenue (2015-2020)
  • 3.1.2 Global Ophthalmic Therapeutics/Drug Revenue Market Share by Players (2015-2020)
• 3.2 Global Ophthalmic Therapeutics/Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Ophthalmic Therapeutics/Drug Revenue
• 3.4 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio
  • 3.4.1 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutics/Drug Revenue in 2019
• 3.5 Key Players Ophthalmic Therapeutics/Drug Area Served
• 3.6 Key Players Ophthalmic Therapeutics/Drug Product Solution and Service
• 3.7 Date of Enter into Ophthalmic Therapeutics/Drug Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Ophthalmic Therapeutics/Drug Breakdown Data by Type (2015-2026)

• 4.1 Global Ophthalmic Therapeutics/Drug Historic Market Size by Type (2015-2020)
• 4.2 Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Type (2021-2026)

5 Ophthalmic Therapeutics/Drug Breakdown Data by Application (2015-2026)

• 5.1 Global Ophthalmic Therapeutics/Drug Historic Market Size by Application (2015-2020)
• 5.2 Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Ophthalmic Therapeutics/Drug Market Size (2015-2026)
• 6.2 North America Ophthalmic Therapeutics/Drug Market Size by Type (2015-2020)
• 6.3 North America Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)
• 6.4 North America Ophthalmic Therapeutics/Drug Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Ophthalmic Therapeutics/Drug Market Size (2015-2026)
• 7.2 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2015-2020)
• 7.3 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)
• 7.4 Europe Ophthalmic Therapeutics/Drug Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Ophthalmic Therapeutics/Drug Market Size (2015-2026)
• 8.2 China Ophthalmic Therapeutics/Drug Market Size by Type (2015-2020)
• 8.3 China Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)
• 8.4 China Ophthalmic Therapeutics/Drug Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Ophthalmic Therapeutics/Drug Market Size (2015-2026)
• 9.2 Japan Ophthalmic Therapeutics/Drug Market Size by Type (2015-2020)
• 9.3 Japan Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)
• 9.4 Japan Ophthalmic Therapeutics/Drug Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Ophthalmic Therapeutics/Drug Market Size (2015-2026)
• 10.2 Southeast Asia Ophthalmic Therapeutics/Drug Market Size by Type (2015-2020)
• 10.3 Southeast Asia Ophthalmic Therapeutics/Drug Market Size by Application (2015-2020)
• 10.4 Southeast Asia Ophthalmic Therapeutics/Drug Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Alcon
  • 11.1.1 Alcon Company Details
  • 11.1.2 Alcon Business Overview
  • 11.1.3 Alcon Ophthalmic Therapeutics/Drug Introduction
  • 11.1.4 Alcon Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020))
  • 11.1.5 Alcon Recent Development
• 11.2 Johnson and Johnson Vision Care, Inc.
  • 11.2.1 Johnson and Johnson Vision Care, Inc. Company Details
  • 11.2.2 Johnson and Johnson Vision Care, Inc. Business Overview
  • 11.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Introduction
  • 11.2.4 Johnson and Johnson Vision Care, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 11.2.5 Johnson and Johnson Vision Care, Inc. Recent Development
• 11.3 Bausch & Lomb Incorporated
  • 11.3.1 Bausch & Lomb Incorporated Company Details
  • 11.3.2 Bausch & Lomb Incorporated Business Overview
  • 11.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Introduction
  • 11.3.4 Bausch & Lomb Incorporated Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 11.3.5 Bausch & Lomb Incorporated Recent Development
• 11.4 Novartis AG
  • 11.4.1 Novartis AG Company Details
  • 11.4.2 Novartis AG Business Overview
  • 11.4.3 Novartis AG Ophthalmic Therapeutics/Drug Introduction
  • 11.4.4 Novartis AG Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 11.4.5 Novartis AG Recent Development
• 11.5 Merck Sharp & Dohme Corp.
  • 11.5.1 Merck Sharp & Dohme Corp. Company Details
  • 11.5.2 Merck Sharp & Dohme Corp. Business Overview
  • 11.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Introduction
  • 11.5.4 Merck Sharp & Dohme Corp. Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 11.5.5 Merck Sharp & Dohme Corp. Recent Development
• 11.6 Regeneron Pharmaceuticals Inc.
  • 11.6.1 Regeneron Pharmaceuticals Inc. Company Details
  • 11.6.2 Regeneron Pharmaceuticals Inc. Business Overview
  • 11.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Introduction
  • 11.6.4 Regeneron Pharmaceuticals Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 11.6.5 Regeneron Pharmaceuticals Inc. Recent Development
• 11.7 Allergan
  • 11.7.1 Allergan Company Details
  • 11.7.2 Allergan Business Overview
  • 11.7.3 Allergan Ophthalmic Therapeutics/Drug Introduction
  • 11.7.4 Allergan Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 11.7.5 Allergan Recent Development
• 11.8 Pfizer Inc.
  • 11.8.1 Pfizer Inc. Company Details
  • 11.8.2 Pfizer Inc. Business Overview
  • 11.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Introduction
  • 11.8.4 Pfizer Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 11.8.5 Pfizer Inc. Recent Development
• 11.9 Valeant
  • 11.9.1 Valeant Company Details
  • 11.9.2 Valeant Business Overview
  • 11.9.3 Valeant Ophthalmic Therapeutics/Drug Introduction
  • 11.9.4 Valeant Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 11.9.5 Valeant Recent Development
• 11.10 Bayer AG
  • 11.10.1 Bayer AG Company Details
  • 11.10.2 Bayer AG Business Overview
  • 11.10.3 Bayer AG Ophthalmic Therapeutics/Drug Introduction
  • 11.10.4 Bayer AG Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 11.10.5 Bayer AG Recent Development
• 11.11 Santen Pharmaceuticals Co. Ltd
  • 10.11.1 Santen Pharmaceuticals Co. Ltd Company Details
  • 10.11.2 Santen Pharmaceuticals Co. Ltd Business Overview
  • 10.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Introduction
  • 10.11.4 Santen Pharmaceuticals Co. Ltd Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 10.11.5 Santen Pharmaceuticals Co. Ltd Recent Development
• 11.12 Genentech, Inc.
  • 10.12.1 Genentech, Inc. Company Details
  • 10.12.2 Genentech, Inc. Business Overview
  • 10.12.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Introduction
  • 10.12.4 Genentech, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2015-2020)
  • 10.12.5 Genentech, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Ophthalmic Therapeutics/Drug Scope and Market Size
Ophthalmic Therapeutics/Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmic Therapeutics/Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others

Market segment by Application, split into
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others

Based on regional and country-level analysis, the Ophthalmic Therapeutics/Drug market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Ophthalmic Therapeutics/Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer Inc.
Valeant
Bayer AG
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.